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Cataract remains the leading cause of blindness world-
wide. Mutations in 29 different genes with diverse functions 
are known to cause inherited congenital cataract, the rare 
form of cataract, with mutations in the crystallin genes being 
the major reported cause [1-3].
More recently, mutations in genes involved in intercel-
lular adhesion have emerged as another cause of inherited 
congenital cataract, indicating the importance of intercel-
lular contacts in lens development and cataractogenesis. The 
full-length isoform of the Nance-Horan Syndrome (NHS) 
gene, NHS-A, associates with epithelial tight junctions; we 
have reported that mutations in this gene cause X-linked 
syndromic cataract in NHS [4-6]. The protein encoded by the 
Ephrin type A receptor-2 (EPHA2) gene regulates epithelial 
cell adhesion [7]. We and other groups found that mutations 
in this gene cause autosomal dominant and recessive forms 
of congenital cataract [8-10]. The EPHA2 gene is also geneti-
cally associated with age-related cortical cataract [9,11,12]. 
Both, the NHS and EPHA2 proteins are expressed in the 
mammalian lens [4,11]. The NHS-A protein localizes at 
cell-cell contacts in the anterior lens epithelium, whereas 
EPHA2 localizes to cell-cell contacts in the equatorial lens 
epithelium and cortical fiber cells [5,11,13]. The mechanisms 
of cataractogenesis involving the NHS and EPHA2 genes are 
poorly understood. Preliminary investigations of the func-
tion of NHS and mechanism of cataract formation in NHS 
were undertaken in nonocular ex vivo models of mammalian 
epithelium, such as Madin-Darby canine kidney (MDCK), 
and human colorectal adenocarcinoma (Caco-2) cells [14,15]. 
This is primarily because whether the lens epithelial cell 
lines derived from the mammalian lens, model an epithe-
lium ex vivo is unknown. Hence, the aim of this study was 
to determine expression and localization of key cell-cell 
contact molecules in established lens epithelial cell lines 
and ascertain whether these cell lines model the mammalian 
epithelium ex vivo.
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The status of intercellular junctions in established lens epithelial 
cell lines
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Department of Ophthalmology, Flinders University, Bedford Park, SA 5042, Australia
Purpose: Cataract is the major cause of vision-related disability worldwide. Mutations in the crystallin genes are the 
most common known cause of inherited congenital cataract. Mutations in the genes associated with intercellular contacts, 
such as Nance-Horan Syndrome (NHS) and Ephrin type A receptor-2 (EPHA2), are other recognized causes of congenital 
cataract. The EPHA2 gene has been also associated with age-related cataract, suggesting that intercellular junctions 
are important in not only lens development, but also in maintaining lens transparency. The purpose of this study was to 
analyze the expression and localization of the key cell junction and cytoskeletal proteins, and of NHS and EPHA2, in 
established lens epithelial cell lines to determine their suitability as model epithelial systems for the functional investiga-
tion of genes involved in intercellular contacts and implicated in cataract.
Methods: The expression and subcellular localization of occludin and zona occludens protein-1 (ZO-1), which are as-
sociated with tight junctions; E-cadherin, which is associated with adherence junctions; and the cytoskeletal actin were 
analyzed in monolayers of a human lens epithelial cell line (SRA 01/04) and a mouse lens epithelial cell line (αTN4). In 
addition, the expression and subcellular localization of the NHS and EPHA2 proteins were analyzed in these cell lines. 
Protein or mRNA expression was respectively determined by western blotting or reverse transcription-polymerase chain 
reaction (RT–PCR), and localization was determined by immunofluorescence labeling.
Results: Human SRA 01/04 and mouse αTN4 lens epithelial cells expressed either the proteins of interest or their en-
coding mRNA. Occludin, ZO-1, and NHS proteins localized to the cellular periphery, whereas E-cadherin, actin, and 
EPHA2 localized in the cytoplasm in these cell lines.
Conclusions: The human SRA 01/04 and mouse αTN4 lens epithelial cells express the key junctional proteins. The 
localization patterns of these proteins suggest that these cell lines form tight junctions but do not form E-cadherin-
based adherence junctions. These data further indicate that the regulatory role of NHS in actin remodeling, suggested 
in another study, is cell type dependent. In conclusion, the SRA 01/04 and αTN4 lens epithelial cell lines model some 
characteristics of an epithelium.
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Epithelial cells adhere together through three types 
of junctional complexes—tight junctions (TJs), adherence 
junctions (AJs), and desmosomes—that are respectively 
distributed apically to basally along the lateral cell membrane 
[16]. TJs define epithelial cell polarity, regulate paracellular 
permeability, and confer barrier function to the epithelia [17]. 
AJs are responsible for cell-cell adhesion and maintaining the 
integrity of TJs [18]. Desmosomes provide anchoring sites for 
cytoskeletal structures, the intermediate filaments [19]. TJs 
are composed of transmembrane proteins, occludins, clau-
dins, and junctional adhesion molecules that interact with the 
cytoplasmic plaque proteins such as zonula occludens (ZO) 
adaptor proteins, and with signaling proteins that regulate 
cell proliferation, migration, and differentiation [20]. TJs are 
linked with the actin cytoskeleton via the ZO proteins. AJs are 
composed of cadherin- and nectin-based adhesion complexes 
[18]. They are also linked with the actin cytoskeleton.
In the present study, we investigated the expression and 
localization of the TJ proteins occludin and ZO-1, the AJ 
protein E-cadherin, and the cytoskeletal protein β-actin in 
two lens epithelial cell lines, namely human SRA 01/04 [21] 
and mouse αTN4 [22] cells. The investigation also included 
the NHS and EPHA2 proteins. The SRA 01/04 cells have 
been immortalized by Simian virus 40 (SV40) large T antigen 
transformation [21] and αTN4 cells have been derived from 
the lens epithelium of transgenic mice expressing SV40 
large-T antigen transgene under the crystallin αA promoter 
[22]. The presented data suggest that the two lens epithelial 
cell lines retain some characteristics of an epithelium in 
culture.
METHODS
Mammalian cell culture: The human SRA 01/04 and mouse 
αTN4 lens epithelial cells were kind gifts from Dr. Venkat 
Reddy (Kellogg Eye Institute, University of Michigan, 
MI) and Dr. Paul Russell (University of California, Davis, 
CA), respectively. Both of the cell lines were cultured in 
Dulbecco’s Modified Eagle’s medium (DMEM; GIBCO, 
Life Technologies Australia Pty Ltd., Mulgrave, Australia) 
supplemented with 10% fetal bovine serum and penicillin/
streptomycin. Cell cultures were maintained in a humidified 
atmosphere at 37 °C and 5% CO2.
Western blot analysis: Cells (4×105 SRA 01/04 or αTN4, per 
well) were seeded in six-well tissue culture plates. After 
approximately 48 h, the cells were harvested and cellular 
proteins extracted using radio-immunoprecipitation assay 
(RIPA) buffer (10 mM HEPES pH 7.5, 150 mM sodium chlo-
ride, 2 mM EDTA, 1% Triton X-100, 0.5% sodium deoxy-
cholate, 0.1% sodium dodecyl sulfate [SDS], 25× protease 
inhibitor cocktail [Roche Diagnostics Australia Pty Ltd., 
Castle Hill, Australia], 57 µM phenylmethylsulfonyl fluoride, 
2 mM sodium orthovanadate, 10 mM sodium pyrophosphate 
and 20 mM sodium fluoride). Forty micrograms of total 
soluble proteins of each cell line were separated on a 10% 
polyacrylamide gel by SDS–PAGE (PAGE) and transferred 
onto Hybond C-extra (GE Healthcare Australia and New 
Zealand, Sydney, Australia). The blot was probed with the 
mouse monoclonal anti-ZO-1 (1:250; Zymed Laboratories, 
Life Technologies Australia Pty Ltd., Mulgrave, Australia), 
anti-occludin (1:250; Zymed Laboratories), anti-E-cadherin 
(1:2,500; BD Transduction Laboratories, North Ryde, 
Australia), anti-β-actin (1:5,000, Sigma-Aldrich Pty Ltd., 
Castle Hill, Australia), or anti-Eck/EphA2 clone D7 (1:500; 
Upstate Biotechnology, Millipore Australia Pty Ltd., Kilsyth, 
Australia) primary antibody. Primary antibody binding was 
detected by hybridization with the sheep anti-mouse IgG–
horseradish peroxidase–conjugated (1:1,000; Chemicon 
Australia Pty Ltd., Boronia, Australia) or donkey anti-mouse 
IgG–horseradish peroxidase–conjugated (1:1,000; Jackson 
ImmunoResearch Laboratories Inc., Brisbane, Australia) 
secondary antibody. MCF-7 breast cancer cell lysate was 
included as a positive control on western blots probed with 
the anti-occludin, anti-E-cadherin, and anti-β-actin anti-
bodies. Antibody binding was detected using the enhanced 
chemulimunescence (ECL) western blotting system (GE 
Healthcare Australia and New Zealand, Sydney, Australia) or 
SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Fisher Scientific, Scoresby, Australia).
Reverse transcription-polymerase chain reaction: Total 
RNA from frozen pellets of SRA 01/04 and αTN4 cells was 
extracted using the RNeasy mini kit (QIAGEN Pty Ltd., 
Doncaster, Australia) following the manufacturer’s protocol. 
First strand cDNA synthesis was performed with Superscript 
III reverse transcriptase (Invitrogen, Life Technologies 
Australia Pty Ltd., Mulgrave, Australia) as per the manufac-
turer’s instructions using random hexamers. On the resulting 
cDNA template, PCR was performed with mouse Occludin-
specific primers 5′-AAG AGT ACA TGG CTG CTG CTG 
ATG-3′ (forward) and 5′ CTT AAT TGG AGT GTT CAG 
CCC AGT-3′ (reverse), and human and mouse E-cadherin-
specific primers 5′-CTG GGC TGG ACC GAG AGA TT-3′ 
(forward) and 5′-GCA GTG TAG GAT GTG ATT TCC TG-3′ 
(reverse) using HotStar Taq (QIAGEN). PCR included dena-
turation at 95 °C for 15 min and 40 cycles of denaturation at 
95 °C for 30 s, annealing at 60 °C for 30 s, and elongation 
at 72 °C for 30 s, for the amplification of Occludin cDNA, 
as well as denaturation at 95 °C for 15 min and 50 cycles 
of denaturation at 95 °C for 30 s, annealing at 56 °C for 30 
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s, and elongation at 72 °C for 30 s for the amplification of 
E-cadherin cDNA.
Immunofluorescent labeling: Cells (3×105 SRA 01/04 or 
αTN4) were seeded onto glass coverslips placed in six-well 
tissue culture plates. Four days later, for immunolabeling, 
the cells were fixed in 4% paraformaldehyde/ phosphate 
buffered saline (PBS), permeabilized with 0.4% Triton 
X-100, blocked with 5% donkey serum, and hybridized with 
rabbit polyclonal anti-ZO-1 (1:250; Zymed Laboratories), 
mouse anti-E-cadherin (1:500), rabbit anti-NHS (1:100–200) 
[5], or mouse monoclonal anti-EphA2 (1:100–500) primary 
antibody. For the labeling of occludin, the cells were fixed 
and permeabilized in chilled ethanol/acetone, blocked with 
PTB (0.1% Triton X-100 and 5% BSA in PBS), and hybridized 
with rabbit polyclonal anti-occludin antibody (1:250; Zymed 
Laboratories). Anti-ZO-1, anti-NHS, and anti-occludin anti-
body binding was detected with Alexa Fluor 488-conjugated 
anti-rabbit IgG (1:1,000; Molecular Probes, Life Technolo-
gies Australia Pty Ltd., Mulgrave, Australia), and binding of 
anti-EphA2 and anti-E-cadherin antibodies with Alexa Fluor 
488-conjugated anti-mouse IgG (1:1,000; Molecular Probes) 
secondary antibody. Nuclei in E-cadherin-labeled cells were 
stained with propidium iodide (Molecular Probes) after treat-
ment with RNase A/T1 cocktail (Ambion, Life Technologies 
Australia Pty Ltd., Mulgrave, Australia). Labeled cells were 
mounted on microscope slides in buffered glycerol (pH 8.6). 
Occludin, ZO-1, E-cadherin, and NHS labeling was visual-
ized on an Olympus BX50 epifluorescence microscope using 
a blue filter and images taken using the AnalySIS software 
(Olympus, Adelaide, SA, Australia). Propidium iodide 
staining was visualized using a green filter. EPHA2 labeling 
was imaged on a Leica TCS SP5 confocal microscope using 
the LAS Image analysis software (Leica Microsystems Pty 
Ltd, North Ryde, NSW, Australia). Alexa Fluor 488 was 
excited with an Argon laser with emission spectrum set at 
492–561 nm.
For localization of actin, confluent SRA 01/04 and αTN4 
cells grown on glass coverslips were fixed in 4% parafor-
maldehyde/PBS, permeabilized with 0.4% Triton X-100, 
stained with phalloidin-tetramethyl rhodamine isothiocyanate 
(TRITC; 1:250, Sigma-Aldrich Pty Ltd.) for 30 min, washed 
several times with PBS, and mounted in Prolong Gold 
Antifade reagent with 4’,6-diamino-2-phenylindole (DAPI; 
Molecular Probes). Actin staining was imaged by confocal 
microscopy as explained above. TRITC was excited with 
DPSS 561 laser line with emission spectrum set at 565–645 
nm.
RESULTS
Expression analysis: Expression of the junctional proteins 
occludin, ZO-1, and E-cadherin, cytoskeletal protein β-actin, 
NHS and EPHA2 proteins, or their encoding genes in SRA 
01/04 and αTN4 cells was respectively analyzed by western 
blotting or reverse transcription-polymerase chain reaction 
(RT–PCR). Western blotting of protein lysates of the two cell 
lines with the anti-ZO-1 antibody revealed a specific protein 
band of ~220 kDa in each cell line that corresponds with the 
expected size of the ZO-1 protein (Figure 1A). Hybridiza-
tion of protein lysates from the two cell lines with the anti-
occludin antibody detected a prominent band of ~60 kDa, the 
expected size of occludin, in SRA 01/04 cells (Figure 1B). A 
similar sized band was also detected in MCF-7 human breast 
cancer cells that were used as a positive control (Figure 1B). 
However, in αTN4 cells, only a faint band of the expected 
size was detected with this antibody. The bands smaller than 
60 kDa in SRA 01/04 and MCF-7 cell lysates likely represent 
occludin isoforms; those larger than 60 kDa in SRA 01/04 
cells may represent incompletely denatured protein. Similar 
hybridization with the anti-E-cadherin antibody did not 
reveal any signal in SRA 01/04 and αTN4 cells, but detected 
a ~100 kDa band corresponding to the expected size of the 
full-length E-cadherin protein in MCF-7 cells (Figure 1C). 
E-cadherin is known to undergo proteolytic cleavage [23]; 
therefore, the protein bands smaller than 100 kDa seen in 
MCF-7 cells may represent its cleavage products. Hybridiza-
tion with the anti-β-actin antibody revealed a protein band 
of ~42 kDa in SRA 01/04 and αTN4 cells, and in the posi-
tive control MCF-7 cells (Figure 1D). The detected band 
corresponds with the expected size of the β-actin protein. 
The absence of a signal with the anti-E-cadherin antibody in 
SRA 01/04 and αTN4 cell lysates, indicating that E-cadherin 
is either not expressed or is expressed at undetectable levels 
in these cells.
Further, to confirm expression of Occludin in αTN4 cells 
and to determine E-cadherin mRNA (mRNA) expression in 
the two cell lines, RT–PCR was performed using gene specific 
primers. RT–PCR of mRNA from αTN4 cells with mouse 
Occludin–specific primers revealed, as expected, a product 
of 378 bp (Figure 2A). Similarly, RT–PCR of mRNA from the 
two cell lines using the human and mouse E-cadherin specific 
primers, as expected, resulted in products of 536 bp and 537 
bp, respectively, in SRA 01/04 and αTN4 cells (Figure 2B). 
The specificity of each amplified product was confirmed by 
sequencing. In summary, RT–PCR data confirmed Occludin 
expression in αTN4 cells and demonstrated expression of 
E-cadherin in SRA 01/04 and αTN4 cells.
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Western blotting of cell lysates from SRA 01/04 and 
αTN4 cells with the anti-EphA2 antibody revealed two 
bands of ~140 kDa and ~108 kDa in the former, and a band 
of ~140 kDa in the latter cells (Figure 3). The EPHA2 protein 
is phosphorylated at several residues and undergoes glycosyl-
ation and ubiquitination [24-27]. The ~140 kDa band in both 
the cell lines likely represents posttranslationally modified 
form of the protein [7]. The smaller ~108 kDa band observed 
in SRA 01/04 cells may represent the unmodified form of 
human EPHA2. The ~50 kDa band in SRA 01/04 cells may 
be a degradation product.
Figure 1. Expression of cellular 
junctions associated and cyto-
skeletal proteins in human SRA 
01/04 and mouse αTN4 lens 
epithelial cells. Western blotting 
was performed on protein lysates 
of SRA 01/04 and αTN4 cells 
using the (A) anti-zona occludin-1 
(ZO-1), (B) anti-occludin, (C) anti-
E-cadherin, and (D) anti-β-actin 
antibodies. Protein lysate of MCF-7 
human breast cancer cells was used 
as a positive control in B, C, and 
D. A: A band of ~220 kilo Daltons 
(kDa) of the expected size of ZO-1 
was detected in each cell line. B: 
A ~60 kDa band corresponding 
to the expected size of occludin 
was detected in SRA 01/04 and 
the positive control MCF-7 cells. 
A very faint band of similar size 
was observed in αTN4 cells. The 
<60 kDa bands in SRA 01/04 
and MCF-7 cells likely represent 
occludin isoforms and >60 kDa 
bands in SRA 01/04 cells likely 
represent nondenatured protein. C: 
A ~100 kDa band corresponding 
to the expected size of the full-
length E-cadherin was detected in 
the positive control MCF-7 cells, 
but no signal was detected in SRA 
01/04 or αTN4 cells. The <100 kDa 
bands in MCF-7 cells are likely 
E-cadherin cleavage products. D: 
A ~42 kDa band of the expected 
size of β-actin was detected in all 
the cell lines. Molecular masses of 
protein standards are indicated in 
kDa. 
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Together, these data demonstrate that ZO-1, β-actin, and 
EPHA2 proteins are expressed in human SRA 01/04 and 
mouse αTN4 cells, and occludin protein is expressed in SRA 
01/04 cells. Furthermore, they demonstrate that Occludin 
mRNA is expressed in αTN4 cells and E-cadherin mRNA 
is expressed in both SRA 01/04 and αTN4 cells. Expression 
of the NHS-A isoform of NHS in these cell lines has been 
previously reported by our group [5].
Protein localization: To determine subcellular distribution 
of the proteins of interest in SRA 01/04 and αTN4 cells, 
immunolabeling was performed in confluent cultures of 
these cells. Immunolabeling with the anti-occludin antibody 
revealed peripheral localization of the protein as punctate 
strands perpendicular to the cell boundary in both cell 
types (Figure 4, occludin panels). The strand-like peripheral 
distribution was more obvious in SRA 01/04 cells due to 
their larger cell size than in αTN4 cells. In some SRA 01/04 
and αTN4 cells cytoplasmic localization of the protein was 
also observed. Immunolabeling of the ZO-1 protein showed 
punctate peripheral localization similar to that of occludin in 
the two cell lines (Figure 4, ZO-1 panels). The ZO-1 signal 
intensity was stronger and the immunopositive strands at 
the cellular periphery appeared longer than those observed 
with the anti-occludin antibody, particularly in SRA 01/04 
cells. Some cytoplasmic distribution of the ZO-1 protein was 
also seen in both SRA 01/04 and αTN4 cells. E-cadherin 
localizes to the peripheral membrane in polarized epithelial 
cells [28]. However, immunolabeling of E-cadherin in SRA 
01/04 and αTN4 cells showed localization of the protein 
in the perinuclear region and in a punctate fashion in the 
cytoplasm (Figure 4, E-cadherin panels). Using the same 
anti-E-cadherin antibody as used in this study, we previously 
reported peripheral membrane localization of the E-cadherin 
protein in MDCK cells [5]. Thus, the intracellular localization 
of E-cadherin seen in SRA 01/04 and αTN4 cells is specific.
Actin is involved in regulating intercellular junctions and 
plays an important role in cell adhesion, cell polarity, cell 
migration, and cell survival [29,30]. In epithelial cells with 
well defined intercellular contacts, it forms a circumferential 
ring parallel to the cell membrane [31]. In the present study, 
in SRA 01/04 and αTN4 cells stained for actin, the protein 
was present in radially arranged filaments in the cytoplasm 
(Figure 4, actin panels).
Both SRA 01/04 and αTN4 cells express the NHS-A 
isoform of NHS. This isoform interacts with the TJ protein 
ZO-1 in polarized epithelium in culture and in the mamma-
lian lens [6]. NHS-A is also involved in regulating actin 
remodeling and cell morphology [15]. Its distribution in SRA 
01/04 and αTN4 cells has not been investigated before; we 
determined this in the present study. Immunolabeling with 
the anti-NHS antibody revealed localization of the protein at 
Figure 2. Expression of Occludin and E-cadherin mRNA in 
human SRA 01/04 and/or mouse αTN4 lens epithelial cells. mRNA 
expression was analyzed by reverse transcription-polymerase 
chain reaction (RT–PCR) using gene specific primers. A: Occludin 
expression in αTN4 cells demonstrated by amplification of a PCR 
product of the expected size of 378 base pairs (bp). B: Expression 
of E-cadherin in SRA 01/04 and αTN4 cells demonstrated by 
amplification of the expected PCR products, respectively, of 536 
and 537 bp. The specificity of each PCR product was confirmed by 
sequencing. Molecular sizes of DNA markers in bp are indicated on 
the left. M indicates DNA marker and RT- indicates without reverse 
transcriptase control.
Figure 3. Expression of the EPHA2 protein in human SRA 01/04 
and mouse αTN4 lens epithelial cells. Western blotting was 
performed on cell lysates of each cell line with the anti-EphA2 
antibody. The specific band of ~140 kilo Daltons (kDa) in the two 
cell lines corresponds to the posttranslationally modified form of 
the protein. The ~108 kDa band in SRA 01/04 cells corresponds to 
the unmodified form of EPHA2 and the ~50 kDa band is likely a 
degradation product. The molecular masses of protein standards 
are indicated in kDa.
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Figure 4. Subcellular localization 
of cellular junctions associated 
and cytoskeletal proteins in human 
SRA 01/04 and mouse αTN4 
lens epithelial cells. Endogenous 
occludin, zona occludin-1 (ZO-1) 
and E-cadherin proteins were 
respectively immunolabeled with 
the anti-occludin, anti-ZO-1, and 
anti-E-cadherin antibodies. The 
cytoskeletal actin was stained with 
phalloidin-TRITC. The labeled 
protein is indicated on the left. 
Occludin (green) localized to the 
cellular periphery as punctate 
strands perpendicular to the cell 
boundary (arrow) in both SRA 
01/04 and αTN4 cells. In the αTN4 
cell panel inset shows magnified 
view of the cell pointed with an 
arrow. In some cells, cytoplasmic 
localization of the protein was also 
observed. ZO-1 (green) also local-
ized to the cellular periphery in a 
strand-like pattern perpendicular to 
the cell boundary in both cell types. 
In the αTN4 cell panel, arrow points 
to a cell with strand-like localiza-
tion; inset shows magnified view of 
the same cell. Cytoplasmic local-
ization of ZO-1 was also observed 
in some cells. E-cadherin (green) 
localized as punctate dots in the 
cytoplasm in both the cell lines; 
nuclei (red) stained with propidium 
iodide. The absence of a signal in 
each cell type upon hybridization 
with the secondary antibody alone 
as a negative control (not shown) 
proved specificity of localization 
of each labeled protein. Actin (red) 
staining showed its localization as 
radial filaments in the cytoplasm 
in both the cell types; nuclei (blue) 
labeled with DAPI. Occludin, 
ZO-1 and E-cadherin labeling was 
detected by epifluorescence micros-
copy using a 40× objective. Actin 
staining was detected by confocal microscopy using a 60× objective and further digital magnification. Representative images from two 
independent experiments are shown. 
Archived at Flinders University: dspace.flinders.edu.au
Molecular Vision 2012; 18:2937-2946 <http://www.molvis.org/molvis/v18/a300> © 2012 Molecular Vision 
2943
the peripheral cell membrane in both SRA 01/04 and αTN4 
cells (Figure 5, NHS-A panels). The protein localized in a 
strandlike pattern perpendicular to the cell membrane in 
αTN4 cells. A similar localization pattern but lower signal 
intensity was observed in SRA 01/04 cells. Weak nuclear 
localization of the protein was also observed in some cells in 
both cell lines (data not shown).
EPHA2 is a class A Eph receptor, involved in cell-cell 
adhesion and repulsion [32]. It localizes to cell-cell contact 
sites and regulates paracellular permeability and cadherin-
based AJs in epithelia [33]. In SRA 01/04 and αTN4 cells, 
labeled for EPHA2, the protein localized in the cytoplasm 
(Figure 5, EPHA2 panels). The cytoplasmic localization in 
SRA 01/04 cells had a speckled appearance and in some cells 
appeared vesicular, whereas in αTN4 cells it was seen as well 
defined elongated specks. In MDCK cells used as a posi-
tive control, as expected, the protein localized to the cellular 
periphery at sites of cell-cell contact.
DISCUSSION
Expression analysis of the TJ proteins occludin and ZO-1 
and the AJ protein E-cadherin in SRA 01/04 and αTN4 cells 
showed that these proteins or their encoding mRNAs are 
expressed in these lens-derived cell lines. While the ZO-1 
protein in both the cell lines, and occludin in SRA 01/04 cells 
were detectable by western blotting, E-cadherin was not. 
In addition, occludin was barely detectable in αTN4 cells. 
However, Occludin mRNA in αTN4 cells and E-cadherin 
mRNA in both the cell lines were detected by RT–PCR, albeit 
after considerable cycles of amplification of the templates (see 
Material and Methods), thus suggesting lower level expression 
of these genes in the respective cell lines and supporting the 
western blotting data. The relatively lower level expression of 
these genes was also supported by amplification of glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) mRNA from 
the same cDNAs after fewer amplification cycles (30 cycles; 
data not shown). Consistent with lower levels of expression, 
weak positive immunoreactivity to the occludin protein in 
αTN4 cells and to the E-cadherin protein in SRA 01/04 and 
αTN4 cells was observed with antibodies specific to each 
protein (Figure 4). Furthermore, the presented expression 
data demonstrate expression of the cytoskeletal actin, and 
the protein product of the cataract-related gene EPHA2 in 
SRA 01/04 and αTN4 cells.
All the proteins investigated in the present study are 
expressed in the mammalian lens and localize to cell-cell 
contacts between lens epithelial cells, between lens fiber 
cells, and/or to the epithelium-fiber interface [5,11,34]. In 
SRA 01/04 and αTN4 cells, only occludin, ZO-1, and NHS-A 
proteins localized at the peripheral cell membrane, indicating 
that these proteins are present at cell-cell contacts (Figure 4 
and Figure 5). On the other hand, localization of E-cadherin, 
Figure 5. Subcellular localization 
of NHS-A and EPHA2 proteins 
in human SRA 01/04 and mouse 
αTN4 lens epithelial cells. Endog-
enous NHS-A and EPHA2 proteins 
were immunolabeled respectively 
with the anti-NHS and anti-EphA2 
antibody. NHS-A localized to 
the cellular periphery as punctate 
strands perpendicular to the cell 
boundary in both the cell types. 
EPHA2 showed uniformly speckled 
localization in the cytoplasm in 
SRA 01/04 cells; in αTN4 cells 
it localized in the cytoplasm as 
discrete specks; in positive control 
Madin-Darby canine k idney 
(MDCK) cells, it localized to the 
cellular periphery. The absence of 
a signal in each cell type upon hybridization with the secondary antibody alone as a negative control (not shown) proved specificity of 
localization of each labeled protein. NHS-A labeling was detected by epifluorescence microscopy using a 40× objective. EPHA2 labeling 
was detected by confocal microscopy using a 60× objective and further digital magnification. Representative images from two independent 
experiments are shown. 
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actin, and EPHA2 proteins in the cytoplasm in these cells 
suggests their absence from cell-cell contacts. The localiza-
tion patterns of NHS-A, ZO-1, and occludin in these cells 
correlate with those in epithelial cells such as MDCK and 
Caco-2 [5,6,15]. While in polarized MDCK and Caco-2 cells 
these proteins form a continuous belt around the cell, in SRA 
01/04 and αTN4 cells, they are associated with punctate 
strands between adjacent cells (Figure 4 and Figure 5). ZO-1 
colocalizes and interacts with NHS-A and occludin in polar-
ized MDCK cells [6]. Whether it colocalizes and interacts 
with these proteins in SRA 01/04 and αTN4 cells will be 
the subject of a future investigation. Localization of ZO-1 
and occludin to strands between adjacent cells is consistent 
with dependence of occludin on ZO-1 for its recruitment to 
TJs [35]; localization of NHS-A and ZO-1 to these strands 
agrees with the correlated localization of these proteins to 
the cell membrane in polarized MDCK cells [6]. Based on the 
localization pattern of these three proteins, it seems that SRA 
01/04 and αTN4 cells form TJs. Nevertheless, the localiza-
tion patterns of E-cadherin, actin, and EPHA2 proteins in 
these cells (Figure 4 and Figure 5) do not correlate with their 
localization in polarized epithelial cells [7,31,36]. As actin is 
involved in AJ assembly [18] and E-cadherin-based AJs are 
regulated by EPHA2 [37], localization of these three proteins 
at cell-cell contacts is interdependent, which may explain their 
collective mislocalization in the cytoplasm in SRA 01/04 and 
αTN4 cells. Furthermore, AJ assembly precedes TJ assembly 
in epithelial cells because TJ formation is dependent upon 
AJ formation [31,38]. However, the absence of E-cadherin 
and EPHA2 from sites of cell-cell contact in SRA 01/04 and 
αTN4 cells suggests the absence of E-cadherin-based AJs 
in these cells. Localization of occludin to punctate strands 
between adjacent cells along with weak expression and 
cytoplasmic localization of E-cadherin has been reported in 
CPC-2 human choroid plexus carcinoma cells and attributed 
to dysregulation of AJs [39]. As SRA 01/04 and αTN4 cells 
have been transformed with the SV40 large-T antigen, they 
are in some ways similar to cancerous cells; therefore, it is 
possible that they have dysregulated AJs and lack E-cadherin 
based AJs. This may further explain the cytoplasmic localiza-
tion of EPHA2 in these cells. Similar formation of TJs in the 
absence of E-cadherin-based AJs and localization of ZO-1 
and occludin to TJs has been reported in thyrocytes from 
E-cadherin conditional knockout mice [40]. In the absence of 
E-cadherin-based AJs, the SRA 01/04 and αTN4 cells may 
form N-cadherin based or nestin-afadin-based AJs. Expres-
sion of N-cadherin in the mouse lens epithelium [11] supports 
such a possibility.
TJs in SRA 01/04 and αTN4 cells have a strandlike 
appearance as opposed to the beltlike appearance in polarized 
epithelia like MDCK cells [41]. This indicates that the former 
cells do not form well defined barrier epithelia even in 
confluent cultures. This idea is consistent with the reported 
lower transepithelial resistance of αTN4 cells (130±7.3 Ω.cm2) 
compared to that of MDCK cells (613±35 Ω.cm2) [42,43]. The 
transepithelial resistance of SRA 01/04 cells has not been 
determined. This also correlates with failure of confluent 
SRA 01/04 and αTN4 cells to arrange in a well defined 
honeycomb pattern, typically exhibited by polarized MDCK 
and Caco-2 cells. Taken together, our data suggest the forma-
tion of nonpolarized epithelia by SRA 01/04 and αTN4 cells. 
This may explain why a circumferential actin ring, present in 
polarized epithelia [44], is absence in these cells.
Interestingly, formation of the circumferential actin ring 
in Caco-2 cells is dependent upon NHS-A expression as its 
knockdown leads to disruption of the actin ring, loss of cell 
shape, and cell spreading [15]. This, however, does not seem 
to be the case in SRA 01/04 and αTN4 cells as they express 
NHS-A and yet do not form a circumferential actin ring, thus 
suggesting that regulation of actin remodeling by NHS-A is 
cell type dependent, and that NHS-A alone is not sufficient 
for this regulation.
The localization patterns of the NHS-A and EPHA2 
proteins in SRA 01/04 and αTN4 cells indicate that their use 
as model systems for studying the mechanism of cataracto-
genesis will depend on the protein under investigation. While 
these cells may prove useful for investigations into the NHS 
gene, they may not be suitable for studying the EPHA2 gene.
In conclusion, we demonstrated the expression of the key 
markers of TJs and AJs and the cytoskeletal protein actin 
in human SRA 01/04 and mouse αTN4 lens epithelial cells. 
The localization data suggest the formation of TJs but not 
E-cadherin-based AJs in these cell lines. Hence, these cells 
lines likely form nonpolarized epithelia. Investigation of 
further junctional molecules would reveal the mechanism of 
cell adhesion in these cell lines.
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